Year in Review: Huntington's Disease

(MedPage Today) -- A new drug was approved for Huntington's chorea in 2023, and novel insights about Huntington's disease emerged in new research. Valbenazine for Huntington's Chorea In August, the FDA expanded the label for valbenazine (Ingrezza...
Source: MedPage Today Neurology - Category: Neurology Source Type: news